glp-1 drug coverage America's Poison Centers Navigating Insurance for GLP-1 Medication:

The government has warned that regulatory surveillance will continue to be intensified in the coming weeks, with non-compliances dealt with strictly through license cancellations, penalties, and prosecution under applicable laws

Blue Cross and BCN will continue covering GLP-1s prescribed to treat Type 2 diabetes, including the medications Ozempic, Mounjaro, Rybelsus and Victoza

Those who continued GLP-1 treatment for two or two-and-a-half years before discontinuing for the remainder of the study also gained significant risk reduction (7% and 15%, respectively)

however, based on thyroid C-cell hyperplasia, adenomas, and medullary thyroid carcinomas observed in studies of these agents in mice (40), all of the GLP-1 receptor agonists except exenatide BID and lixisenatide are contraindicated in patients with a personal or family history of medullary thyroid carcinoma and in patients with multiple endocrine neoplasia syndrome type 2 (1418)

Daily weight fluctuates by 1 to 3 pounds from water, sodium, and digestive contents

Type 2 diabetes is the most common cause of CKD, and both diabetes and CKD are associated with increased all-cause mortality and increased rates of infection and cardiovascular events